Background/Objectives: Plasma leptin and adiponectin, and membrane phospholipid fatty acid composition are implicated into the mechanism of insulin resistance but no clear pattern has emerged. Hence, this study examined these variables in subjects presenting to the diabetic clinic for a diagnostic glucose tolerance test. Subjects/Methods: Body composition, glucose, glycated hemoglobin, insulin, leptin, adiponectin, and red cell and plasma phospholipid fatty acids were assessed from 42 normal and 28 impaired glucose tolerant subjects. Insulin sensitivity was determined by homeostatic model assessment. Results: The plasma phosphatidylcholine fatty acid composition of the impaired glucose tolerant subjects was similar to that of normal subjects. However, the impaired glucose tolerant subjects had significantly lower linoleic (Po0.05), eicosapentaenoic (Po0.05) and docosahexaenoic (Po0.01) acids in the red cell phosphatidylcholine and phosphatidylethanolamine compared with the normal subjects. Moreover, red cell phosphatidylcholine docosahexaenoic acid correlated positively with adiponectin (r ¼ 0.290, Po0.05) but negatively with leptin (r ¼ À0.252, Po0.05), insulin (r ¼ À0.335, Po0.01) and insulin resistance (r ¼ À0.322, Po0.01). Plasma triglycerides, leptin and glucose combined predicted about 60% of variation in insulin level whereas insulin was the only component that predicted the membrane fatty acids. Conclusions: We postulate that membrane phospholipids fatty acids have an indirect role in determining insulin concentration but insulin has a major role in determining membrane fatty acid composition.
Introduction
Adiponectin, leptin and long-chain omega-3 fatty acids are recognized as bioactive substances that have anti-obesity and insulin-sensitizing effects (Friedman and Halaas, 1998; Spranger et al., 2003; Delarue et al., 2004; Nishida et al., 2007; Flachs et al., 2009) . Both adiponectin and leptin are predominantly expressed and secreted by adipose tissue and the plasma concentrations are associated with fat mass in a divergent manner, that is, the bigger fat mass, the higher leptin but lower adiponectin (Maffei et al., 1995; Considine et al., 1996; Fisher et al., 2002; Nakamura et al., 2008) . This pattern is also found in individuals with increased insulin resistance (Almeida-Pititto et al., 2005; Esteghamati et al., 2009) .
One of the other factors that influence insulin sensitivity is membrane phospholipid fatty acid composition. Clore et al. (2000) have demonstrated that insulin resistance was negatively correlated with the long-chain omega-3 fatty acids of the muscle membrane phosphatidylcholine. We have also demonstrated that the alteration of fatty acid composition was most profound in the red cell phosphatidylcholine of the gestational diabetic women known to be insulin resistant (Min et al., 2004) . The red cell membrane bilayer consists of different combinations of phospholipids; phosphatidylcholine being the predominant phospholipid of the outer and phosphatidylethanolamine the inner leaflet (Verkleij et al., 1973; Roelofsen and Zwaal, 1976) . Moreover, alteration in fatty acids composition of the phospholipids is associated with changes in insulin binding in rats (Field et al., 1990; Fickova et al., 1998) .
Thus, fat mass, plasma leptin and adiponectin, and membrane phospholipid fatty acid composition are all implicated in the mechanism of insulin action. However, the association between membrane phospholipid fatty acid composition and plasma leptin and adiponectin in relation to insulin resistance in humans has not been reported. Therefore, this study examines the relationship between these variables in a group of subjects who presented to the diabetic clinic for a diagnostic glucose tolerance test.
Subjects and methods

Subjects
Seventy patients referred by their general practitioners to the Diabetic and Endocrine Day Centre, St Thomas Hospital (London) for a diagnostic oral glucose tolerance were studied. Pregnant women and subjects who were on a long-term steroids medication were excluded. Ethical approval was granted from the St Thomas' Hospital Ethics Committee and a written consent form was obtained from the participants in accordance with the Helsinki Declaration II.
Body composition measurements
Body weight and height were measured on a scale. Total fat mass was determined by the bioelectrical impedance analysis technique using the TANITA Bodyfat Analyser (Model TBF-105, TANITA Corporation Europe GmbH-Sindelfingen, Germany).
Procedure, blood sampling and assays Blood samples were taken at fasting and 120 min after administration of 75 g of glucose. Insulin sensitivity was determined by the homeostasis model assessment insulin resistance (fasting insulin (mU/l) Â fasting plasma glucose (mmol/l)/22.5). Subjects were categorized according to their plasma glucose level at 120 min; those with the value of o7.8 mmol/l was considered as normal and those with the value of equal and 47.8 mmol/l were classed as impaired glucose tolerant (WHO 2006) . Plasma glucose, glycated hemoglobin and triglycerides were assayed by the Roche Cobas Mira Plus Biochemistry Analyser (Roche Diagnostics Ltd, West Sussex, UK). Plasma insulin was quantified by the Roche Elecsys (Model 2010, Hitachi; Roche Diagnostics, Indianapolis, IN, USA), and leptin and adiponectin by the use of Triturus automated ELISA workstation (Diagnostic Grifols, Barcelona, Spain). For fatty acid analysis, red cells were separated from plasma by centrifugation (3000 r.p.m. for 15 min at 4 1C) and washed once with an equal volume of 0.85% saline and stored at À70 1C until analysis. Triglycerides, leptin, adiponectin, and plasma and red cell phospholipid fatty acids were measured from fasting blood only.
Red cell and plasma phospholipids fatty acids analysis Red cell and plasma total lipids were extracted by the method of Folch et al. (1957) by homogenizing the samples in chloroform and methanol (2:1 by volume) containing 0.01% of butylated hydroxytoluene as an antioxidant under nitrogen. Phospholipid fractions were separated from the total lipids by thin-layer chromatography on silica plates using the developing solvents, chloroform:methanol:water (60:30:4) containing 0.01% butylated hydroxytoluene. Bands were detected by spraying with 2,7-dichlorofluorosciene and visualized under ultraviolet light. The phosphatidylcholine and phosphatidylethanolamine from the red cells and phosphatidylcholine from the plasma were recovered from the plates. Fatty acid methyl esters were then prepared in 15% acetyl chloride in dry methanol solution at 70 1C for 3 h and separated using a gas-liquid chromatograph (HRGC MEGA 2 Series, Fisons Instruments, Milan, Italy) fitted with a BP20 capillary column (25 m Â 0.32 mm i.d., 0.25 mm film). Hydrogen was used as a carrier gas and the injector, oven, and detector temperatures were 250, 200 and 280 1C, respectively. The fatty acid methyl esters were identified by comparison of retention time with authentic standards. Peak areas were quantified by a computer chromatography data system EZChrom Elite (v3.2, Scientific Software, Pleasanton, CA, USA).
Statistical analysis
Values are expressed as means±s.d. Two-tailed independent sample t-test was used to compare the test variables between normal and impaired glucose tolerant subjects. Variables that were not normally distributed were log transformed before the analysis, however, all data reported in the table are true values. The bivariate correlations between adiopnectin, leptin, insulin sensitivity and fatty acids were assessed by computing Pearson's correlation coefficient with a two-tailed significance. Moreover, a linear stepwise regression model with a use of probability of F (0.05) was used to establish predictive variables for insulin. In this model, the dependent variable was insulin and the independent variables considered in the equation were age, fat mass, glucose, adiponectin, leptin, triglycerides, red cell phosphatidylcholine linoleic, eicosapentaenoic, docosahexaenoic and palmitic acids. Both tests (bivariate correlation and regression analysis) were carried out in whole study population. All statistical analyses were performed using PASW Statistic 8 (2010 SPSS Inc., Chicago, IL, USA).
Results
Subjects were grouped according to their glucose tolerant status; normal and impaired glucose tolerant. The anthropometric and biochemical measurements are shown in Table 1 . Individuals with impaired glucose tolerance were older (Po0.05), shorter (Po0.05) and heavier (Po0.001)
Red cell fatty acids and adipokines Y Min et al with a greater fat mass (Po0.001) than those with normal glucose tolerance. Moreover, subjects with impaired glucose tolerance had higher triglyceride (Po0.001) and leptin (Po0.001) concentration compared with the normal subjects. However, the plasma adiponectin concentration was significantly lower in the individuals with impaired glucose tolerance (Po0.001).
Overall, the plasma phosphatidylcholine fatty acid composition did not differ between the two groups. However, the subjects with impaired glucose tolerance had reduced level of linoleic acid (18:2o6, Po0.01) but higher total saturated fatty acids (Po0.01) ( Table 2 ). In contrast, a significant difference was found in the red cells phospholipids (Table 3 ). The red cell phosphatidylcholine of the individuals with impaired glucose tolerance was characterized by a higher levels of palmitic acid (16:0) (Po0.01), oleic acid (18:1) (Po0.05), and total saturated (Po0.01) and monounsaturated (Po0.01) fatty acids but lower linoleic acid (Po0.01), eicosapentaenoic acid (20:5o3) (Po0.05), docosahexaenoic acid (22:6o3) (Po0.01), and total omega-6 (Po0.01) and omega-3 (Po0.01) fatty acids. A similar profile was observed in the red cell phosphatidylethanolamine (Table 3) .
No consistent association was found between leptin, adiponectin, and fatty acids of the plasma and red cell phospholipids. The correlation coefficients between leptin, adiponectin, insulin and fatty acids are summarized in Table 4 . In the plasma phosphatidylcholine, stearic acid correlated positively with leptin (Po0.01) and negatively with adiponectin (Po0.01). On the other hand, docosahexaenoic acid of the red cell phosphatidylcholine inversely associated with leptin (Po0.05) but showed a direct relationship with adiponectin (Po0.05). Similarly, the red cell phosphatidylethanolamine eicosapentaenoic acid showed a similar association with leptin (Po0.01) and adiponectin (Po0.01).
A positive relationship was found between red cell phosphatidylcholine palmitic acid (Po0.01) and insulin. Conversely, an inverse correlation was found between plasma insulin, and red cell phosphatidylcholine linoleic acid (Po0.01), eicosapentaenoic acid (Po0.01) and 33.9 ± 3.9 33.0 ± 2.7 NS Total o3 6 . 5 ± 2.2 5.9 ± 1.6 NS Abbreviation: NS, nonsignificant. docosahexaenoic acid (Po0.01). Moreover, the ratio of total omega-3 fatty acids and saturated fatty acids of the red cell phosphatidylcholine was negatively associated with insulin (Po0.01). Similar associations were found between the phosphatidylethanolamine fatty acids and insulin. Yet, no association was observed between glucose and red cell fatty acids. In order to establish predictive variables for insulin, the following parameters (age, fat mass, glucose, adiponectin, leptin, triglycerides, red cell phosphatidylcholine linoleic, eicosapentaenoic, docosahexaenoic and palmitic acids-all fasting values) were entered into the stepwise regression analysis. The suggested model indicated that the triglycerides, leptin and glucose combined (r ¼ 0.810, Po0.0001) could explain about 60% of variation in insulin concentration. We repeated the same procedure as above for the red cell phosphatidylcholine docosahexaenoic and eicosapentaenoic acids instead of insulin. In both cases, insulin came out as the only variable that could predict the variation of docosahexaenoic acid (r ¼ 0.335, P ¼ 0.001) and eicosapentaenoic acid (r ¼ 0.311, P ¼ 0.005) in the red cell phosphatidylcholine. However, it is worth noting that this model could only explain approximately 9% of variation in red cell docosahexaenoic or eicosapentaenoic acids levels.
Discussion
Similar to our previous observation in gestational diabetic women (Min et al., 2004 (Min et al., , 2006 , there was a distinctive difference in the red cell phospholipids fatty acid composition in the individuals with impaired glucose tolerance; lower linoleic, arachidonic, eicosapentaenoic and docosahexaenoic acids but higher palmitic acid. Yet, the plasma fatty acids were not affected with the exception of linoleic acid and total saturated fatty acids. Red cells lack the ability of de novo fatty acid synthesis, consequently they take up the fatty acids from the plasma and incorporate them into phospholipids via deacylation and reacylation process (Kuypers 2007) . Insulin is considered one of the contributing factors that influence this process (Le Petit-Thévenin et al., 1988; Dang et al., 1991) . By using 3 H-labelled palmitic, oleic and arachidonic acids, Le Petit-Thévenin et al. have shown that insulin deficiency impaired primarily the acylation of phosphatidylcholine in streptozotocin-induced diabetic rats. Interestingly, the phosphatidylethanolamine of the diabetic rats was not affected; Dang et al. (1991) have also demonstrated that insulin deficiency resulted in reduced incorporation of fatty acids including arachidonic and eicosapentaenoic acids in the erythrocytes isolated from the diabetic rats. This impairment was rectified in insulin-treated diabetic rats. Although these findings are derived from insulin-deficient animal models, it is plausible that hyperinsulinemia could also impair this process. Indeed, there is some evidence of red cell membrane lipid alteration (that is, shift in the proportion of various phospholipids) in type 2 diabetic patients (Makar et al., 1995; Allen et al., 2006; Ramel et al., 2009) . Thus, previous findings illustrate that insulin concentration may have a role in determining membrane fatty acid composition.
In addition to the specific changes in red cell membrane fatty acids, we have also observed an inverse correlation between red cell membrane omega-3 fatty acids to saturated fatty acid ratio and insulin sensitivity (and fasting insulin). It is conceivable that the balance of membrane fatty acids could also influence insulin action. Our observation is supported by Ramel et al. (2009) who reported enhanced insulin sensitivity in individuals who were given fish oil (rich in long-chain omega-3 fatty acids) only if it was complemented with a calorie-restricted diet (that is, reduced saturated fat intake). Similarly, a 6-month hypocaloric lowfat combined with lean (white) fish diet altered the balance of saturated (reduced) and omega-3 (increased) fatty acids in the skeletal muscle membrane phospholipids in grossly obese/diabetic patients and this change was significantly associated with change in insulin sensitivity (Guebre-Egziabher et al., 2008) . However, it is worth noting that despite the normalization of muscle membrane phospholipid fatty acid, the increased omega-3 fatty acids failed to lower the absolute concentration of circulating insulin.
In this study, we have found that both eicosapentaenoic and docosahexaenoic acids of red cell phospholipids were positively associated with circulating adiponectin. Previously, dietary intervention studies have demonstrated that increased long-chain omega-3 fatty acids intake raises circulating adiponectin concentration in lean (Itoh et al., 2007) and obese (Kamboj et al., 2009) subjects. It appears eicosapentaenoic and/or docosahexaenoic acids are involved in the adiponectin synthesis through yet unknown mechanism. One of the possible mechanisms proposed was that these fatty acids activate peroxisome proliferator-activated receptor-g, which in turn stimulate adiponectin synthesis in adipocyte and subsequently increase its secretion into the circulation (Pérez-Matute et al., 2005; Neschen et al., 2006; Banga et al., 2009; Flachs et al., 2009) . Leptin concentration, on the other hand, was inversely associated with membrane eicosapentaenoic and docosahexaenoic acids. Recently, leptin-lowering effect of long-chain omega-3 fatty acids (fish oil) has been demonstrated in dietinduced rodent model of obesity (Rossi et al., 2005; Selenscig et al., 2010) . Plasma leptin concentration is closely linked with fat mass and fat mass itself can be modulated by longchain omega-3 fatty acids as we have previously observed (Aurora et al., 2005) . In this preliminary study, we have found that supplementation of 10 g of fish oil (MAXEPA) daily for 2 months shifted the fat (lost 4.3 kg) and muscle (gained 2.3 kg) mass without affecting body weight, plasma insulin level or insulin sensitivity in obese (mean body mass index 32.9 kg/m 2 ) type 2 diabetic patients. In summary, we have found bivariate relationships between insulin, adiponectin, leptin and membrane phospholipids fatty acids, particularly with eicosapentaenoic and docosahexaenoic acids. Moreover, the outcome of the stepwise regression analysis suggests that triglycerides, leptin and glucose combined predicted about two-thirds of variation in insulin concentration, hence insulin sensitivity. Conversely, insulin was the only component that predicted the membrane fatty acids. Therefore, we postulate that membrane phospholipids fatty acids have an indirect role in determining insulin concentration but insulin has a major role in determining membrane fatty acid composition.
